mab35 Search Results


jurkat e6 1 cells  (ATCC)
94
ATCC jurkat e6 1 cells
Jurkat E6 1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/bio_rxiv__64898__2026__03__09__710629-166-0-7?v=ATCC
Average 94 stars, based on 1 article reviews
jurkat e6 1 cells - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
monoclonal antibody mab 35  (ATCC)
94
ATCC monoclonal antibody mab 35
Monoclonal Antibody Mab 35, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/pm09360963-50-1-24?v=ATCC
Average 94 stars, based on 1 article reviews
monoclonal antibody mab 35 - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
mab 35  (Bio X Cell)
93
Bio X Cell mab 35
Mab 35, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/pm40020066-189-0-2?v=Bio+X+Cell
Average 93 stars, based on 1 article reviews
mab 35 - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
monoclonal anti achrα antibody mab35  (Developmental Studies Hybridoma Bank)
92
Developmental Studies Hybridoma Bank monoclonal anti achrα antibody mab35
Monoclonal Anti Achrα Antibody Mab35, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/pmc03361077-65-6-11?v=Developmental+Studies+Hybridoma+Bank
Average 92 stars, based on 1 article reviews
monoclonal anti achrα antibody mab35 - by Bioz Stars, 2026-07
92/100 stars
  Buy from Supplier
rat monoclonal antibody mab  (Developmental Studies Hybridoma Bank)
94
Developmental Studies Hybridoma Bank rat monoclonal antibody mab
Rat Monoclonal Antibody Mab, supplied by Developmental Studies Hybridoma Bank, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/pmc02739421-102-19-12?v=Developmental+Studies+Hybridoma+Bank
Average 94 stars, based on 1 article reviews
rat monoclonal antibody mab - by Bioz Stars, 2026-07
94/100 stars
  Buy from Supplier
mab35 (rat anti-achr tool ab)  (GeneTex)
90
GeneTex mab35 (rat anti-achr tool ab)
(A) Schematic representation of Myasthenia Gravis disease biology driven by anti-AChR autoantibodies. (B–F) AF647 α-Bungarotoxin (in red) and nuclear stain (in blue) binding to cells transfected with AChRα1β1δϵ+Rapsyn (B) , AChRα1β1δϵ (C) , AChRα1β1 (D) , AChRδϵ (E) , Untransfected control cells (F, G) IgG, IgA, and IgM quantification of immunoglobulin-depleted vs. non-depleted NHS. (H) Haemolytic activity of immunoglobulin-depleted vs. non-depleted NHS. (I) Binding profile (IgG+IgA+IgM binding) of non-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (J) Binding profile (IgG+IgA+IgM binding) of immunoglobulin (Ig)-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (K) AChR decrease in AChR+Rapsyn-transfected cells incubated with tool anti-AChR antibody <t>mAb35</t> in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). (L) Increased MAC deposition in AChR positive cells, incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). All NHS used and referred to in the remainder of the paper is Ig-depleted NHS. ****p <0.0001.
Mab35 (Rat Anti Achr Tool Ab), supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/pmc09486540-223-2-7?v=GeneTex
Average 90 stars, based on 1 article reviews
mab35 (rat anti-achr tool ab) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
anticaspase-2 mab 35  (Becton Dickinson)
90
Becton Dickinson anticaspase-2 mab 35
(A) Schematic representation of Myasthenia Gravis disease biology driven by anti-AChR autoantibodies. (B–F) AF647 α-Bungarotoxin (in red) and nuclear stain (in blue) binding to cells transfected with AChRα1β1δϵ+Rapsyn (B) , AChRα1β1δϵ (C) , AChRα1β1 (D) , AChRδϵ (E) , Untransfected control cells (F, G) IgG, IgA, and IgM quantification of immunoglobulin-depleted vs. non-depleted NHS. (H) Haemolytic activity of immunoglobulin-depleted vs. non-depleted NHS. (I) Binding profile (IgG+IgA+IgM binding) of non-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (J) Binding profile (IgG+IgA+IgM binding) of immunoglobulin (Ig)-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (K) AChR decrease in AChR+Rapsyn-transfected cells incubated with tool anti-AChR antibody <t>mAb35</t> in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). (L) Increased MAC deposition in AChR positive cells, incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). All NHS used and referred to in the remainder of the paper is Ig-depleted NHS. ****p <0.0001.
Anticaspase 2 Mab 35, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/pm15356645-24-56-74?v=Becton+Dickinson
Average 90 stars, based on 1 article reviews
anticaspase-2 mab 35 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mab 35  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare mab 35
(A) Schematic representation of Myasthenia Gravis disease biology driven by anti-AChR autoantibodies. (B–F) AF647 α-Bungarotoxin (in red) and nuclear stain (in blue) binding to cells transfected with AChRα1β1δϵ+Rapsyn (B) , AChRα1β1δϵ (C) , AChRα1β1 (D) , AChRδϵ (E) , Untransfected control cells (F, G) IgG, IgA, and IgM quantification of immunoglobulin-depleted vs. non-depleted NHS. (H) Haemolytic activity of immunoglobulin-depleted vs. non-depleted NHS. (I) Binding profile (IgG+IgA+IgM binding) of non-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (J) Binding profile (IgG+IgA+IgM binding) of immunoglobulin (Ig)-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (K) AChR decrease in AChR+Rapsyn-transfected cells incubated with tool anti-AChR antibody <t>mAb35</t> in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). (L) Increased MAC deposition in AChR positive cells, incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). All NHS used and referred to in the remainder of the paper is Ig-depleted NHS. ****p <0.0001.
Mab 35, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/10__1523_slash_jneurosci__17___21___08201__1997-38-0-16?v=Johns+Hopkins+HealthCare
Average 90 stars, based on 1 article reviews
mab 35 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
mab35 antibody  (CRP Inc)
90
CRP Inc mab35 antibody
(A) Schematic representation of Myasthenia Gravis disease biology driven by anti-AChR autoantibodies. (B–F) AF647 α-Bungarotoxin (in red) and nuclear stain (in blue) binding to cells transfected with AChRα1β1δϵ+Rapsyn (B) , AChRα1β1δϵ (C) , AChRα1β1 (D) , AChRδϵ (E) , Untransfected control cells (F, G) IgG, IgA, and IgM quantification of immunoglobulin-depleted vs. non-depleted NHS. (H) Haemolytic activity of immunoglobulin-depleted vs. non-depleted NHS. (I) Binding profile (IgG+IgA+IgM binding) of non-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (J) Binding profile (IgG+IgA+IgM binding) of immunoglobulin (Ig)-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (K) AChR decrease in AChR+Rapsyn-transfected cells incubated with tool anti-AChR antibody <t>mAb35</t> in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). (L) Increased MAC deposition in AChR positive cells, incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). All NHS used and referred to in the remainder of the paper is Ig-depleted NHS. ****p <0.0001.
Mab35 Antibody, supplied by CRP Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab35/10__1074_slash_jbc__m108845200-64-18-34?v=CRP+Inc
Average 90 stars, based on 1 article reviews
mab35 antibody - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


(A) Schematic representation of Myasthenia Gravis disease biology driven by anti-AChR autoantibodies. (B–F) AF647 α-Bungarotoxin (in red) and nuclear stain (in blue) binding to cells transfected with AChRα1β1δϵ+Rapsyn (B) , AChRα1β1δϵ (C) , AChRα1β1 (D) , AChRδϵ (E) , Untransfected control cells (F, G) IgG, IgA, and IgM quantification of immunoglobulin-depleted vs. non-depleted NHS. (H) Haemolytic activity of immunoglobulin-depleted vs. non-depleted NHS. (I) Binding profile (IgG+IgA+IgM binding) of non-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (J) Binding profile (IgG+IgA+IgM binding) of immunoglobulin (Ig)-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (K) AChR decrease in AChR+Rapsyn-transfected cells incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). (L) Increased MAC deposition in AChR positive cells, incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). All NHS used and referred to in the remainder of the paper is Ig-depleted NHS. ****p <0.0001.

Journal: Frontiers in Immunology

Article Title: Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic AChR positive Myasthenia Gravis patients

doi: 10.3389/fimmu.2022.968206

Figure Lengend Snippet: (A) Schematic representation of Myasthenia Gravis disease biology driven by anti-AChR autoantibodies. (B–F) AF647 α-Bungarotoxin (in red) and nuclear stain (in blue) binding to cells transfected with AChRα1β1δϵ+Rapsyn (B) , AChRα1β1δϵ (C) , AChRα1β1 (D) , AChRδϵ (E) , Untransfected control cells (F, G) IgG, IgA, and IgM quantification of immunoglobulin-depleted vs. non-depleted NHS. (H) Haemolytic activity of immunoglobulin-depleted vs. non-depleted NHS. (I) Binding profile (IgG+IgA+IgM binding) of non-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (J) Binding profile (IgG+IgA+IgM binding) of immunoglobulin (Ig)-depleted NHS to transfected cells (blue: nuclear stain; red: AF647 anti-human IgG+IgA+IgM). (K) AChR decrease in AChR+Rapsyn-transfected cells incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). (L) Increased MAC deposition in AChR positive cells, incubated with tool anti-AChR antibody mAb35 in the presence of Ig-depleted NHS (n = 30) (One-way ANOVA (GraphPad Prism), Tukey’s multiple comparisons test). All NHS used and referred to in the remainder of the paper is Ig-depleted NHS. ****p <0.0001.

Article Snippet: A 10μg/ml mAb35 (Rat anti-AChR tool Ab, Genetex) solution was also prepared in culture medium.

Techniques: Staining, Binding Assay, Transfection, Control, Activity Assay, Incubation